First isolation of a carbapenem-hydrolyzing β-lactamase in Pseudomonas aeruginosa in Spain

被引：37

作者：

Prats, G

Miro, E

Mirelis, B

Poirel, L

Bellais, S

Nordmann, P ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Santa Cruz & San Pablo, Barcelona 08025, Spain

[2] Fac Med Paris Sud, Hop Paris, Hop Bicetre, Le Kremlin Bicetre, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 03期

关键词：

D O I：

10.1128/AAC.46.3.932-933.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：932 / 933

页数：2

共 11 条

[1] Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase [J].

Cornaglia, G ;

Mazzariol, A ;

Lauretti, L ;

Rossolini, GM ;

Fontana, R .

CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) :1119-1125

[2] Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate [J].

Lauretti, L ;

Riccio, ML ;

Mazzariol, A ;

Cornaglia, G ;

Amicosante, G ;

Fontana, R ;

Rossolini, GM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1584-1590

[3] Carbapenemases: a problem in waiting? [J].

Livermore, DM ;

Woodford, N .

CURRENT OPINION IN MICROBIOLOGY, 2000, 3 (05) :489-495

[4] Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece [J].

Mavroidi, A ;

Tsakris, A ;

Tzelepi, E ;

Pournaras, S ;

Loukova, V ;

Tzouvelekis, LS .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) :1041-1043

[5]

National Committee for Clinical Laboratory Standards, 2000, METH DIL ANT SUSC TE

[6]

Pallecchi L, 2001, FEMS MICROBIOL LETT, V195, P145, DOI 10.1111/j.1574-6968.2001.tb10512.x

[7] Characterization of class 1 integrons from Pseudomonas aeruginosa that contain the blaVIM-2 carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes [J].

Poirel, L ;

Lambert, T ;

Türkoglü, S ;

Ronco, E ;

Gaillard, JL ;

Nordmann, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :546-552

[8] Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France [J].

Poirel, L ;

Naas, T ;

Nicolas, D ;

Collet, L ;

Bellais, S ;

Cavallo, JD ;

Nordmann, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) :891-897

[9] Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems [J].

Senda, K ;

Arakawa, Y ;

Nakashima, K ;

Ito, H ;

Ichiyama, S ;

Shimokata, K ;

Kato, N ;

Ohta, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) :349-353

[10] Metallo-β-lactamases in clinical Pseudomonas isolates in taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme [J].

Yan, JJ ;

Hsueh, PR ;

Ko, WC ;

Luh, KT ;

Tsai, SH ;

Wu, HM ;

Wu, JJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2224-2228

← 1 2 →